Skip to content

Acute STROke Complicating TAVI - Management and Outcomes

Management and Outcomes of Acute STROke Complicating Transcatheter Aortic Valve Implantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05241821
Acronym
ASTRO-TAVI
Enrollment
484
Registered
2022-02-16
Start date
2021-06-01
Completion date
2022-02-05
Last updated
2022-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis, Periprocedural Complication, Stroke

Keywords

periprocedural stroke, transcatheter aortic valve implantation, transcatheter aortic valve replacement

Brief summary

Periprocedural complications of trans catheter aortic valve implantation, and particularly the occurrence of stroke has a marked impact on survival and quality of life. The characteristics of periprocedural stroke complicating TAVI, and particularly of interventions aimed to treat stroke complicating TAVI have not been systematically described. We therefore aimed is to explore the incidence and characteristics of acute stroke complicating TAVI and to describe the safety and efficacy of emergent interventions to treat acute stroke complicating TAVI.

Interventions

PROCEDUREMechanical thrombectomy

Percutaneous intervention aimed to retrieve/treat clot affecting the cerebral circulation.

Drug aimed to dissolve thrombus affecting the cerebral circulation

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* patients who have had a stroke within 30 days of TAVI

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
All cause mortality1-yearAll cause death
Neurologic disability free survival90 daysmodified rankin score (mRS) 0/1

Secondary

MeasureTime frameDescription
Bleeding complications30 daysSevere bleeding / life-threatening bleeding as defined by VARC2 criteria

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026